Croatian Society for Infectious Diseases of the Croatian

  • Slides: 16
Download presentation
Croatian Society for Infectious Diseases of the Croatian Medical Association What are the effects

Croatian Society for Infectious Diseases of the Croatian Medical Association What are the effects of antimicrobial stewardship programmes – cost-reduction and much more? Marija Santini University Hospital for Infectious Diseases “Dr Fran Mihaljevic” Zagreb, 7. 12. 2018.

Antimicrobial stewardship (AMS) programme - what is an adequate Croatian term? Upravljanje, rukovođenje, nadzor,

Antimicrobial stewardship (AMS) programme - what is an adequate Croatian term? Upravljanje, rukovođenje, nadzor, vođenje, kontrola, poboljšanje primjene…

Antimicrobial stewardship programme – why? • Acinetobacter baumannii – ↑carbapenem resistant >80% • Klebsiella

Antimicrobial stewardship programme – why? • Acinetobacter baumannii – ↑carbapenem resistant >80% • Klebsiella pneumoniae – ↑ ESBL 30%, carbapenemase producing… • Pseudomonas aeruginosa – carbapenem resistant 15 -30% • Enterococcus faecium – ↑VRE 18% • Staphylococcus aureus – ↑ MRSA 16% Annual Reports of the Committee for Antibiotic Resistance Surveillance in Croatia, Croatian Academy of Medical Sciences, 31 – 40 centers (90% of population)

Antimicrobial stewardship programme… • May, 2018 • Croatian Society for Infectious Diseases an official

Antimicrobial stewardship programme… • May, 2018 • Croatian Society for Infectious Diseases an official • attempt to introduce the AMS into the Health Care Act, coming into force on 1 January 2019

Does Croatia need AMS programmes? Hospital consumption of antibiotics ATC J 01 DH –

Does Croatia need AMS programmes? Hospital consumption of antibiotics ATC J 01 DH – carbapenems Courtesy of Prim. Marina Payer-Pal, Institute for Public Health of Međimurje County, Croatia Simpozij povodom obilježavanja Europskog dana svjesnosti o antibioticima i Svjetskog tjedna svjesnosti o antibioticima Zagreb, 16. studenoga 2018.

Does Croatia need AMS programmes? Hospital consumption of antibiotics ATC J 01 XA –

Does Croatia need AMS programmes? Hospital consumption of antibiotics ATC J 01 XA – vancomycin Simpozij povodom obilježavanja Europskog dana svjesnosti o antibioticima i Svjetskog tjedna svjesnosti o antibioticima Zagreb, 16. studenoga 2018. Courtesy of Prim. Marina Payer-Pal, Institute for Public Health of Međimurje County, Croatia

Does Croatia need AMS programmes? Hospital consumption of antibiotics ATC J 01 XB –

Does Croatia need AMS programmes? Hospital consumption of antibiotics ATC J 01 XB – colistin Simpozij povodom obilježavanja Europskog dana svjesnosti o antibioticima i Svjetskog tjedna svjesnosti o antibioticima Zagreb, 16. studenoga 2018. Courtesy of Prim. Marina Payer-Pal, Institute for Public Health of Međimurje County, Croatia

Some forgotten facts about antibiotics and some questions • Antibiotics are still powerful •

Some forgotten facts about antibiotics and some questions • Antibiotics are still powerful • The only medication that can stop lethal illness • The only medication that has an effect on the individual and on the community • Are we dealing with antibiotics carefully enough? • Should antibiotics be a general good?

Ø Hospital Quality Indicators (QI) 1. Broj rehospitalizacija unutar 30 dana od otpusta bez

Ø Hospital Quality Indicators (QI) 1. Broj rehospitalizacija unutar 30 dana od otpusta bez obzira na dijagnozu 2. Opća stopa smrtnosti 3. Stopa smrtnosti zbog akutnog infarkta miokarda 4. Stopa smrtnosti zbog moždanog inzulta § § measure quality of the health services provided allow mutual hospital comparison in: 5. Postotak liječenja u dnevnoj bolnici § § 10. Prosječna duljina boravka zbog carskog reza quality of health care provided progress in achieving better quality of health care 6. Postotak prijema kroz hitni prijem 7. Prosječna duljina boravka u bolnici zbog akutnog pankreatitisa – MKB-10: K 85. 8. Prosječna duljina boravka u bolnici zbog akutnog infarkta miokarda- MKB-10: I 21. 9. Prosječna duljina boravka u bolnici zbog inzulta - MKB-10: I 63 11. Prosječna duljina boravka u bolnici zbog hernioplastike ingvinalne hernije- MKB-10: K 40. 9 12. Postotak pacijenata liječenih rezervnim antibiotikom - % od patients treated by the reserve group antibiotics 13. Postotak prijema zbog astme 14. Postotak prijema zbog kronične opstruktivne plućne bolesti (KOPB) 15. Postotak prijema zbog dijabetesa 16. Postotak prijema zbog hipertenzije 17. Postotak slučajeva jednodnevne kirurgije zbog hernioplastike ingvinalne hernije 18. Postotak slučajeva jednodnevne kirurgije zbog operacije katarakte 19. Postotak slučajeva jednodnevne kirurgije zbog operacije adenoidektomija/tonzilektomija 20. Postotak slučajeva jednodnevne kirurgije zbog transuretralne resekcije prostate (TURP) 21. Postotak slučajeva jednodnevne kirurgije zbog laparoskopske kolecistektomije 1. 2. 2022.

Potrošnja rezervnih antibiotika (1. mj. 2016. -7. mj. 2017. ) 14, 00 12, 00

Potrošnja rezervnih antibiotika (1. mj. 2016. -7. mj. 2017. ) 14, 00 12, 00 10, 00 9, 57 11, 42 11, 40 10, 93 10, 88 12, 18 11, 84 11, 33 10, 98 10, 39 9, 57 10, 06 9, 57 9, 54 9, 51 8, 90 8, 00 7, 91 7, 82 7, 918, 08 7, 91 7, 36 7, 918, 11 7, 91 7, 91 7, 12 6, 00 4, 00 2, 00 Postotak pacijenata liječenih rezervnim antibiotikom ŠIBENIK Medijan -Postotak pacijenata liječenih rezervnim antibiotikom HR Courtesy of Dr. Blaša Bilić, General Hospital Šibenik, Croatia 7. ) 01 7. ) 7. (2 01 7. ) 6. (2 01 7. ) 5. (2 01 ) 7. 4. (2 01 3. (2 01 7. ) ) 7. 2. (2 01 6. ) 1. (2 01 11 01. (2 10 . (2 6. ) ) 6. 01 6. ) 9. (2 01 6. ) 8. (2 01 6. ) 7. (2 01 6. ) 6. (2 01 ) 6. 5. (2 01 6. ) 4. (2 01 ) 6. 3. (2 01 2. (2 1. (2 01 6. ) 0, 00

What are the effects of antimicrobial stewardship programmes? Patient, physician and societal perspective •

What are the effects of antimicrobial stewardship programmes? Patient, physician and societal perspective • Decreased numbers of prescriptions for nonbacterial infections • Proper management of known infections ('bug–drug' mismatches) • Less adverse events • Lower C. difficile incidence • Better guidelines adherence • Shorter use of antibiotics • Shorter hospitalization • ↓ resistance rate • Responsibility for off-label antibiotic use Authorities – decision-makers perspective • Cost-minimization Patient safety, good clinical practice & costoptimization

But… • Antimicrobial stewardship programmes are heterogenous • Different methods • Different teams •

But… • Antimicrobial stewardship programmes are heterogenous • Different methods • Different teams • Different settings (general ward, haematology, ICU, urology, outpatient, chronic care facilities. . . ) • Antimicrobial stewardship programmes depend on HCAI control measures • Outcomes/effects are heterogenous

5 How to present jointly the costs and effects of different measures? • Cost-effectiveness

5 How to present jointly the costs and effects of different measures? • Cost-effectiveness Analysis (CEA) • Change in costs and change in health benefits due to an intervention • Incremental Cost Effectiveness Ratio(ICER) Δ cost = Δ effectiveness = cost per QALY

7 $$$ More Cost More costly but more effective More costly and less effective

7 $$$ More Cost More costly but more effective More costly and less effective More Effective Less effective Cost savings less effective More effective and cost savings $ Courtesy of Sonali Coulter, Ph. D, Queensland University of Technology, Brisbane, Australia Cost savings

Conclusions • Antimicrobial stewardship programmes - measure of patient safety, good clinical practice and

Conclusions • Antimicrobial stewardship programmes - measure of patient safety, good clinical practice and cost optimization • The structures of antimicrobial stewardship programmes are diverse and the observed effects are diverse - standardization required (adapted to the state economic possibilities) • Today, the cost-effectiveness analysis is increasingly emphasized

Thanks to… • Vesna Mađarić, ID specialist, General Hospital Koprivnica, Croatia • Marina Payer-Pal,

Thanks to… • Vesna Mađarić, ID specialist, General Hospital Koprivnica, Croatia • Marina Payer-Pal, CM, Institute for Public Health of Međimurje County, Croatia • Committee for Antibiotic Resistance Surveillance in Croatia • Intersectoral Coordination Mechanism for the Control of Antimicrobial Resistance (Interdisciplinarna sekcija za kontrolu rezistencije na antibiotike – ISKRA) • Blanša Bilić, ID specialist, General Hospital Šibenik, Croatia • Sonali Coulter, Ph. D, Queensland University of Technology, Brisbane, Australia • Silvija Šoprek, CM specialist, University Hospital for Infectious Diseases • Arijana Pavelić, professor, head of the library, University Hospital for Infectious Diseases, Zagreb, Croatia • Jasminka Blaha, administrative secretary, Croatian Society for Infectious Diseases